AKT1 and breast carcinoma: In MDA-MB-231 breast cancer cells, PEDF decreases the overall abundance of insulin receptor substrate 1 (IRS1), which is known to limit the downstream p-AKT pathway and, consequently, the cancer cell survival and proliferation [39].